Molotinib (Ojjaara) Side Effects Summary

As an innovative drug, molotinib plays a pivotal role in the treatment of myelofibrosis. Its unique ingredients and mechanism of action can effectively target the pathological characteristics of myelofibrosis, slow down the progression of the disease, and significantly improve the patient's quality of life. However, like other drugs, molotinib can come with a range of side effects. Patients should pay special attention when using it and report any abnormalities to their doctors in a timely manner.

The primary concern is that molotinib may increase the risk of infection. Symptoms of infection are diverse, including but not limited to fever, diarrhea, chills, vomiting, etc. Once these signs appear, patients should inform their doctor immediately so that timely intervention can be taken.

Additionally, molotinib may affect blood cell counts. Changes in blood cell counts may lead to bleeding tendencies such as abnormal bleeding, bruising, or dark stools. Therefore, doctors perform blood tests before and periodically during treatment to monitor the patient's blood cells.

Molotinib may also affect liver function, manifested by increases in liver enzymes and bilirubin. Symptoms of liver problems may include fatigue, dark urine, loss of appetite, and more. Doctors will regularly test patients' liver enzyme levels to ensure that the effects of drugs on the liver are within control.

Of note, taking molotinib may increase the risk of major cardiac events in patients with cardiac risk factors or a history of smoking. Symptoms of a heart attack or stroke include, but are not limited to, persistent chest pain, shortness of breath, nausea or vomiting, slurred speech, feeling lightheaded, etc. If these symptoms occur, patients should seek emergency medical help immediately.

Molotinib may also increase the risk of thrombosis, especially in patients with a past history of venous thrombosis. Signs of blood clots may include leg swelling, pain, or sudden chest pain and difficulty breathing.

In addition to the more serious side effects mentioned above, molotinib also has some common side effects, such as low platelet count, dizziness, bleeding, diarrhea, etc. Although these side effects are mild, they still require the patient's attention and the doctor's appropriate adjustments.

In general, molotinib, as a therapeutic drug, can effectively control the disease, but it may also cause a series of side effects. Patients should pay close attention to their physical condition during use and promptly report any discomfort to the doctor to ensure the safety and effectiveness of the treatment.